Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 66 (3) , 263-270
- https://doi.org/10.1016/j.jinf.2012.12.004
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazoleJournal of Antimicrobial Chemotherapy, 2012
- Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's diseaseJournal of Antimicrobial Chemotherapy, 2011
- How should classic Whipple disease be managed?Nature Reviews Gastroenterology & Hepatology, 2010
- Acquired Resistance to Trimethoprim‐Sulfamethoxazole during Whipple Disease and Expression of the Causative Target GeneThe Journal of Infectious Diseases, 2008
- Prevalence of AsymptomaticTropheryma whippleiCarriage among Humans and Nonhuman PrimatesThe Journal of Infectious Diseases, 2008
- Whipple's disease: new aspects of pathogenesis and treatmentThe Lancet Infectious Diseases, 2008
- Whipple's DiseaseNew England Journal of Medicine, 2007
- Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic mediumJournal of Antimicrobial Chemotherapy, 2005
- Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsiesGastroenterology, 1996
- Short-Term Antibiotic Treatment in Whipple’s DiseaseJournal of Clinical Gastroenterology, 1991